IDH2 and acute myeloid leukemia: Recently, Linch et al. also reported improved survival of AML patients carrying IDH2 R172 variant compared with a historical IDH2 R172 cohort presenting with poor prognosis, relating increased use of alloHCT as consolidation after CR1 with longer OS in the later cohort, as induction strategy was almost unchanged and patients of the later cohort were even significantly older [54].